Analyst ratings are a significant factor influencing investor sentiment and stock price. The positive ratings for Aldeyra Therapeutics suggest a bullish outlook, which could drive the stock price up in the short term. However, the decrease in the average price target could indicate a less optimistic view of the company's future performance, which could temper the positive impact of the ratings.